Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Credit agrmnt [a]
Director departure
Inv. presentation
Quarterly results
Acq. announced
|
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2015 |
8-K
| Investor presentation |
| 03/07/2012 |
8-K
| Form 8-K - Current report |
| 03/15/2010 |
8-K
| Investor presentation|
Docs:
|
"Articles of Incorporation, as currently in effect",
"Bylaws, as currently in effect",
"2009 Stock Incentive Plan",
"Pharmaceuticals Agreement, by and between Pernix Therapeutics, Inc. and Macoven Pharmaceuticals, L.L.C",
"Employment and Non-Compete Agreement, by and between Pernix Therapeutics, Inc. and Michal Venters",
"Employment Non-Compete Agreement, by and between Pernix Therapeutics, Inc. and Cooper Collins",
"Letter from BDO Seidman, LLP to the SEC",
"—",
"—",
"Cowen and Company Healthcare Conference Presentation" |
|
|
|